StockSelector.com
  Research, Select, & Monitor Tuesday, October 22, 2019 6:47:12 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
AngioDynamics$14.72$.09.62%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

AngioDynamics has an overall rank of 1175 out of 7004 stocks based on 15 positive rankings and 4 negative rankings.

Positive Rankings
Highest Cash Growth
AngioDynamics rank is 68
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, AngioDynamics is ranked 144.
Up EPS Surprise
AngioDynamics beat the consensus earnings estimate when it last reported quarterly earnings.
Low Put/Call
AngioDynamics has a low Put/Call ratio of 0.21 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, AngioDynamics is ranked 506.
Oversold Stochastics
AngioDynamics rank is 638
Low vPut/Call
AngioDynamics has a low Put/Call ratio of 0.41 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, AngioDynamics is ranked 704.
Debt-to-Equity
AngioDynamics rank is 798
Highest ROA
AngioDynamics rank is 985
Price-to-Book
AngioDynamics rank is 1027
Historic EPS Growth
AngioDynamics rank is 1302
Estimated Revenue Growth
AngioDynamics rank is 1344
Highest ROE
AngioDynamics rank is 1790
Highest Net Margin
AngioDynamics rank is 1905
Price-to-Sales
AngioDynamics rank is 2200
10 Day Gain
AngioDynamics rank is 2433
Negative Rankings
Negative Guidance
Within the past 90 days AngioDynamics has provided guidance belwo the consensus estimates. Statistics show companies that provide negative guidance underperform the market in the short-term.
Down Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have decreased by a combined (44.74%). Among companies that have had their estimates lowerec within the past month, AngioDynamics is ranked 38.
Negative Revenue Growth
AngioDynamics rank is 555
90 Day Loss
AngioDynamics rank is 742







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.